Kyle is currently an MBA candidate at Ross School of Business while holding a Bachelors and Masters degree in Biomedical Engineering, from Michigan State University and Wayne State University, respectively.

Kyle is currently applying his academic studies and strategically consulting with the early stage startup SpinTech MRI, where he is delivering on business development initiatives as the company attempts to utilize Artificial Intelligence to improve existing MRI technologies. Prior to his current engagement, he held multiple roles, with the most recent being a key engineer in commercialization efforts for an IVD biotech startup, NeuMoDx Molecular, which was successfully acquired by QIAGEN in 2020 for over $250 million dollars. Before helping with the commercialization of a novel IVD machine, Kyle cut his chops at Meridian Health Plan, where among many other things, he helped build an in-house system to aid with strategic payment processing.

He is leveraging his extensive background in the biotech and healthcare industries to help strategically grow, commercialize and invest in biotech and life science companies located in the metro Detroit area.